Ownership history in CITADEL ADVISORS LLC · 57 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in MEI PHARMA INC (MEIP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,378,311 | +1,323,411 | +2410.6% | 0.00% | $1.8M | — |
| 2025 Q4 | REDUCED | 54,900 | -2,046,370 | -97.4% | 0.00% | $72K | — |
| 2025 Q3 | ADDED | 2,101,270 | +2,079,770 | +9673.3% | 0.00% | $5.1M | — |
| 2025 Q3 | REDUCED | 21,500 | -46,000 | -68.1% | 0.00% | $52K | — |
| 2025 Q3 | ADDED | 67,500 | +30,354 | +81.7% | 0.00% | $163K | — |
| 2025 Q1 | ADDED | 37,146 | +36,546 | +6091.0% | 0.00% | $81K | — |
| 2025 Q1 | REDUCED | 600 | -12,000 | -95.2% | 0.00% | $1K | — |
| 2025 Q1 | REDUCED | 12,600 | -24,065 | -65.6% | 0.00% | $28K | — |
| 2024 Q4 | ADDED | 36,665 | +24,065 | +191.0% | 0.00% | $90K | — |
| 2024 Q4 | ADDED | 12,600 | +12,200 | +3050.0% | 0.00% | $31K | — |
As of 2025 Q4 — sorted by position size